El Khassawna Thaqif, Böcker Wolfgang, Brodsky Katharina, Weisweiler David, Govindarajan Parameswari, Kampschulte Marian, Thormann Ulrich, Henss Anja, Rohnke Marcus, Bauer Natali, Müller Robert, Deutsch Andreas, Ignatius Anita, Dürselen Lutz, Langheinrich Alexander, Lips Katrin S, Schnettler Reinhard, Heiss Christian
Laboratory of Experimental Trauma Surgery, Justus-Liebig University, Giessen, Germany.
Department of Trauma Surgery, University Hospital of Giessen-Marburg, Rudolf-Buchheim-Strasse 7, 35385, Giessen, Germany.
Histochem Cell Biol. 2015 Nov;144(5):491-507. doi: 10.1007/s00418-015-1356-9. Epub 2015 Jul 26.
Bone loss is a symptom related to disease and age, which reflects on bone cells and ECM. Discrepant regulation affects cell proliferation and ECM localization. Rat model of osteoporosis (OVX) was investigated against control rats (Sham) at young and old ages. Biophysical, histological and molecular techniques were implemented to examine the underlying cellular and extracellular matrix changes and to assess the mechanisms contributing to bone loss in the context of aging and the widely used osteoporotic models in rats. Bone loss exhibited a compromised function of bone cells and infiltration of adipocytes into bone marrow. However, the expression of genes regulating collagen catabolic process and adipogenesis was chronologically shifted in diseased bone in comparison with aged bone. The data showed the involvement of Wnt signaling inhibition in adipogenesis and bone loss due to over-expression of SOST in both diseased and aged bone. Further, in the OVX animals, an integrin-mediated ERK activation indicated the role of MAPK in osteoblastogenesis and adipogenesis. The increased PTH levels due to calcium and estrogen deficiency activated osteoblastogenesis. Thusly, RANKL-mediated osteoclastogenesis was initiated. Interestingly, the data show the role of MEPE regulating osteoclast-mediated resorption at late stages in osteoporotic bone. The interplay between ECM and bone cells change tissue microstructure and properties. The involvement of Wnt and MAPK pathways in activating cell proliferation has intriguing similarities to oncogenesis and myeloma. The study indicates the importance of targeting both pathways simultaneously to remedy metabolic bone diseases and age-related bone loss.
骨质流失是一种与疾病和年龄相关的症状,反映在骨细胞和细胞外基质上。不同的调节会影响细胞增殖和细胞外基质定位。在年轻和老年阶段,对骨质疏松大鼠模型(去卵巢大鼠)与对照大鼠(假手术大鼠)进行了研究。采用生物物理、组织学和分子技术来检查潜在的细胞和细胞外基质变化,并评估在衰老背景下以及大鼠广泛使用的骨质疏松模型中导致骨质流失的机制。骨质流失表现为骨细胞功能受损以及脂肪细胞浸润到骨髓中。然而,与老年骨相比,调节胶原蛋白分解代谢过程和脂肪生成的基因表达在患病骨中按时间顺序发生了变化。数据表明,由于硬化蛋白在患病骨和老年骨中均过度表达,Wnt信号抑制参与了脂肪生成和骨质流失。此外,在去卵巢动物中,整合素介导的ERK激活表明丝裂原活化蛋白激酶在成骨细胞生成和脂肪生成中发挥作用。钙和雌激素缺乏导致甲状旁腺激素水平升高,从而激活成骨细胞生成。因此,启动了RANKL介导的破骨细胞生成。有趣的是,数据显示基质细胞外磷酸糖蛋白在骨质疏松性骨后期调节破骨细胞介导的吸收中发挥作用。细胞外基质与骨细胞之间的相互作用改变了组织的微观结构和特性。Wnt和丝裂原活化蛋白激酶途径在激活细胞增殖中的作用与肿瘤发生和骨髓瘤有引人注目的相似之处。该研究表明同时靶向这两条途径对于治疗代谢性骨病和与年龄相关的骨质流失的重要性。